For the first time the physical properties of therapeutic carbon-ion beam supplied by, the shallow-seated tumor therapy terminal at the Heavy Ion Research Facility in Lanzhou (HIRFL) are measured. For a 80.55MeV/u C-12 ion beam delivered to the therapy terminal, the homogeneity of irradiation fields is 73.48%, when the beam intensity varied in the range of 0.001-0.1nA (i.e. 1 X 10(6) - 1 X 10(8) particles per second). The stability of the beam intensity within a few minutes is estimated to be 80.87%. The depth-dose distribution of the beam at the isocenter of the therapy facility is measured, and the position of the high-dose Bragg peak is found to be located at the water-equivalent depth of 13.866mm. Based on the relationship between beam ...
The features of relativistic carbon-ion beams are attractive from the viewpoint of radiotherapy. The...
Carbon therapy is increasing worldwide for treating some radioresistant tumours due to its better co...
It is important for carbon-ion radiotherapy to evaluate biological dose distributions accurately in ...
Up to now, clinical trials of heavy-ion radiotherapy for superficially placed tumors have been carri...
Superficially-placed tumors have been treated with carbon ions at the Institute of Modern Physics (I...
Basic research related to heavy-ion cancer therapy has been done at the Institute of Modern Physics ...
1.Heavy-ion radiotherapy has two clear advantages over other types of radiation therapies. One is t...
Radiation therapy for cancer by using heavy ions has attracted considerable attention. The accelerat...
Over 3000 cancer patients have already been treated with 140- to 400-MeV/n carbon beams produced by ...
The passive beam delivery system in the superficially-placed tumor therapy terminal at Heavy Ion Res...
In 1994, carbon ion radiotherapy was begun at the National Institute of Radiological Sciences usingt...
Purpose:Using the carbon ion beam for range measurements instead of photons would avoid the uncertai...
(Introduction)As the best use of the Bragg curve nature, hypofractionated ion-beam therapy has been ...
Carbon-ion therapy was begun in 1994 at the National Institute fir Radiological Sciences using HIMAC...
Purpose: Successful results in carbon-ion and proton radiotherapies can extend patients\u27 lives an...
The features of relativistic carbon-ion beams are attractive from the viewpoint of radiotherapy. The...
Carbon therapy is increasing worldwide for treating some radioresistant tumours due to its better co...
It is important for carbon-ion radiotherapy to evaluate biological dose distributions accurately in ...
Up to now, clinical trials of heavy-ion radiotherapy for superficially placed tumors have been carri...
Superficially-placed tumors have been treated with carbon ions at the Institute of Modern Physics (I...
Basic research related to heavy-ion cancer therapy has been done at the Institute of Modern Physics ...
1.Heavy-ion radiotherapy has two clear advantages over other types of radiation therapies. One is t...
Radiation therapy for cancer by using heavy ions has attracted considerable attention. The accelerat...
Over 3000 cancer patients have already been treated with 140- to 400-MeV/n carbon beams produced by ...
The passive beam delivery system in the superficially-placed tumor therapy terminal at Heavy Ion Res...
In 1994, carbon ion radiotherapy was begun at the National Institute of Radiological Sciences usingt...
Purpose:Using the carbon ion beam for range measurements instead of photons would avoid the uncertai...
(Introduction)As the best use of the Bragg curve nature, hypofractionated ion-beam therapy has been ...
Carbon-ion therapy was begun in 1994 at the National Institute fir Radiological Sciences using HIMAC...
Purpose: Successful results in carbon-ion and proton radiotherapies can extend patients\u27 lives an...
The features of relativistic carbon-ion beams are attractive from the viewpoint of radiotherapy. The...
Carbon therapy is increasing worldwide for treating some radioresistant tumours due to its better co...
It is important for carbon-ion radiotherapy to evaluate biological dose distributions accurately in ...